0 CHECKOUT

Colombia Pharmaceuticals and Healthcare Report Q4 2015

  • ID: 3344709
  • August 2015
  • Region: Colombia
  • 116 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Laboratorios Bussié
  • Laboratorios Genfar SA
  • Lafrancol
  • Merck & Co
  • Novartis
  • MORE

A growing burden of chronic diseases, along with the Colombian government's push toward improving its national healthcare system will ensure the country's retained appeal to multinational drugmakers and healthcare suppliers. Despite remaining concerns surrounding Colombia's counterfeit drug market, the country's overwhelming demand for medical access will keep health and medicine spending on a positive trajectory over the long term.

Headline Expenditure Projections
- Pharmaceuticals: COP8,643bn (USD4.3bn) in 2014 to COP9,110bn (USD3.6bn) in 2015; +5.4% in local currency terms. Forecast revised upward from Q215 due to historical data.

- Healthcare: COP53,417bn (USD26.7bn) in 2014 to COP57,414bn (USD22.4bn) in 2015; +7.5% in local currency terms. Forecast revised upward from Q215 due to historical data.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Laboratorios Bussié
  • Laboratorios Genfar SA
  • Lafrancol
  • Merck & Co
  • Novartis
  • MORE

SWOT

Political

Economic

Operational Risk

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Colombia 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Colombia 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Colombia 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Colombia 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Colombia 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Colombia 2013-2019)

Key Risks To Forecast Scenario

Macroeconomic Forecasts

Economic Analysis
Table: Colombia - Key Economic Indicators
Table: Colombia - Private Consumption Forecasts
Table: Colombia - Government Consumption Forecasts
Table: Colombia - Fixed Investment Forecasts
Table: Colombia - Net Exports Forecasts

Industry Risk Reward Indices

Americas Risk/Reward Index - Q4 2015

Colombia Risk/Reward Index

Rewards

Risks

Market Overview

Industry Trends And Developments

Epidemiology

Healthcare Sector
Table: Healthcare Resources (Colombia 2009-2014)
Table: Healthcare Personnel (Colombia 2009-2014)
Table: Healthcare Activity (Colombia 2009-2014)

Research And Development
Table: Pharmaceutical Research and Science Centre (CECIF) Members, 2015

Clinical Trials

Regulatory Development

Intellectual Property Regime
Table: Colombia-US FTA Mechanisms Relevant To Intellectual Property

Pricing Regime

Reimbursement Regime

Competitive Landscape

Research-Based Industry
Table: Members Of Asociación De Laboratorios Farmacéuticos De Investigación (AFIDRO), 2012
Table: Leading Pharmaceutical Companies By Revenues, 2011 (COPmn)

Pharmaceutical Distribution
Table: Leading Pharmaceutical Importers/Wholesalers By Revenues, 2011

Pharmaceutical Retail

Company Profile

GlaxoSmithKline

Laboratorios Bussié

Laboratorios Genfar SA

Lafrancol

Merck & Co

Novartis

Pfizer

Sanofi

Tecnoquímicas

Demographic Forecast
Table: Population Headline Indicators (Colombia 1990-2025)
Table: Key Population Ratios (Colombia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Colombia 1990-2025)
Table: Population By Age Group (Colombia 1990-2025)
Table: Population By Age Group % (Colombia 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline
Laboratorios Bussié
Laboratorios Genfar SA
Lafrancol
Merck & Co
Novartis
Pfizer
Sanofi
Tecnoquímicas

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.